Inactive Instrument

Genzyme Corporation Share Price

Stocks

End-of-day quote Nasdaq Other stock markets
- ^USD	-

28/06/11	GENZYME CORP.GNL : Mipomersen Data Presented at European Atherosclerosis Society Congress	PU
07/03/11	GENZYME CORP.GNL : Genzyme Board Unanimously Recommends that Shareholders Accept sanofi-aventis Revised Offer and Tender Shares	BU
01/03/11	GENZYME CORP.GNL : Genzyme Completes Sale of Pharmaceuticals Business to International Chemical Investors Group	BU
28/02/11	GENZYME CORP.GNL : Genzyme Recognizes International Rare Disease Day by Launching New Patient Advocacy Grant Program	BU
18/02/11	GENZYME CORP.GNL : Three-Year Data from Phase 2 Trial of Genzyme Gaucher Disease Oral Compound Suggest Sustained or Further Improvement Across All Endpoints	BU

28/06/11	SANOFI : Sanofi/Mipomersen efficace dans l'hypercholestérolémie
04/04/11	Genzyme : succès de l'OPE de Sanofi-aventis.
07/03/11	Genzyme : Sanofi-aventis modifie son offre.
16/02/11	GENZYME CORP.GNL : Résultat trimestriel de Genzyme dans la fourchette annoncée
16/02/11	Genzyme : racheté par Sanofi-Aventis.

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ARGENX SE	-0.92%	+4.18%	+77.50%	+133.89%	58.73B
WUXI APPTEC CO., LTD.	-3.12%	+3.48%	+72.79%	+94.67%	53.92B
BIONTECH SE	+3.86%	+8.38%	-9.90%	-9.62%	24.67B
INSMED INCORPORATED	+4.30%	+6.82%	+13.60%	+428.91%	24.19B
WUXI BIOLOGICS (CAYMAN) INC.	+4.74%	+13.68%	+45.58%	-1.42%	18.8B
GENMAB A/S	-0.72%	+9.43%	+44.16%	-28.17%	17.61B
PHARMAESSENTIA CORPORATION	+2.57%	+16.74%	+171.12%	+355.99%	16.25B
EXELIXIS, INC.	+3.50%	+4.92%	+26.07%	+192.26%	14.04B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+6.72%	+19.38%	+42.82%	-	13.9B
Average	+2.32%	+8.85%	+53.75%	+145.81%	26.9B
Weighted average by Cap.	+0.97%	+7.21%	+57.57%	+136.14%

Employees

Sector